Position in INSM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$360,908
+$61,994 QoQ
Shares Held
3,385
+85.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#435
of 663 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026OSTRUM ASSET MANAGEMENT holds $8,656,924 across 7 Biotechnology names. INSM ranks #6 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
99,352 | $5,570,666 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,403 | $696,912 | |
| 3 | INCY |
Incyte Corp
|
5,280 | $598,540 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
920 | $573,656 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,788 | $538,241 | |
| 6 | INSM |
INSMED Inc
This page
|
3,385 | $360,908 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,698 | $318,001 |
All Filings in INSM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $360,908 | 3,385 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $298,914 | 1,828 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $313,446 | 1,801 | Shares | Defined | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||